Share: 
Status: 
Active
Rating: 
No votes yet
0

On Demand 2016 Immunity Gone Bad (MOC)

Course description

You can earn up to 1.5 AMA PRA Category 1 Credit(s)™. This activity has also been designated by the ABAI for 1.5 MOC Part II Self-Assessment credits. 

Allergist-immunologists need to be knowledgeable about the possible non-infectious complications in their immunodeficient patients. This session will focus on understanding the mechanisms of autoimmunity in primary immune deficiencies and the role of the inflammasome, providing practitioners with knowledge to assist with the recognition of these complications and the prescription of the appropriate disease-modifying medications.

Release Date: 12/01/2016
Expiration Date: 11/30/2019

Accreditation

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Learning objectives: 
  • Recognize and treat the autoimmune complications of primary immunodeficiency
  • Describe the role of the inflammasome in innate immunity and disease
  • Describe autoimmune complications and autoinflammatory syndromes and the use of biologics in their treatment
Credits
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
  • 1.50 MOC
Additional information
Disclosure: 
  • Lisa J. Kobrynski, MD, MPH, FACAAI, Moderator – Consultant/Advisor: Baxter, CSL Behring; Supported/ Contracted Research: Baxter, Grifols
  • Thomas A. Fleisher, MD, FACAAI – Nothing to disclose
  • Hal M. Hoffman, MD – Consultant/Advisor: Novartis; Speaker: Novartis
  • Lori Broderick, MD, PhD -- Consultant/Advisor: Novartis, SOBI

This activity is supported by independent educational grants from the following commercial supporters:

AstraZeneca Partial support of Workshop W24 on Managing Severe Asthma in Adults and Children.

Boston Scientific Supporter of the Virtual Roundtable on Advancing Management of Severe Asthma: A Review of Available Evidence to Guide Current Treatment.

CSL Behring Supporter of the Friday Symposium on Diagnosis and Treatment of Primary Immune Deficiency.

Dormer Laboratories Inc. In-kind support consisting of loaned durable equipment for Workshop W6 on Office Procedures for Allergic Skin Diseases.

GlaxoSmithKline Supporter of the Sunday Symposium on What to Do When Asthma Does Not Respond to Step 3 Treatment…and partial support of Workshop W24 on Managing Severe Asthma in Adults and Children.

Karl Storz Endoscopy-America, Inc. In-kind support consisting of loaned durable equipment for Workshops W12, W15 and W17 – Hands-On Session in Rhinolaryngoscopy.

Meda Pharmaceuticals, Inc. Supporter of the Monday Plenary Session on Asthma in 2016: Advances in Understanding Origin, Presentation and Approaches to Management.

Micro Direct, Inc. In-kind support consisting of loaned durable equipment for Workshops AHP3 and AHP6 Nuts and Bolts of Spirometry Interpretation.

Mylan Specialty L.P. Supporter of the Friday Breakfast Symposium on Leading the Pack: Allergists as Anaphylaxis Experts.

Nestlé Nutrition Institute Supporter of Workshop W11 on Food Allergies: What’s New in Prevention and Treatment.

Regeneron Pharmaceuticals/ Sanofi Genzyme Partial support of the Monday Plenary Session on Modern Therapies for Allergic Skin Diseases.

Salix Pharmaceuticals Partial support of the Friday Luncheon Symposium on Early Recognition and Effective Management of Hereditary Angioedema…and a video session of the symposium.

Shire Partial support of the Friday Luncheon Symposium on Early Recognition and Effective Management of Hereditary Angioedema…and the Sunday Symposium on Immunoglobulin Replacement for the Allergist: Update on Guidelines.

SmartPractice In-kind support consisting of loaned durable equipment for Workshop W6 on Office Procedures for Allergic Skin Diseases.

Teva Respiratory Supporter of the Friday Symposium on The Use of Biologics in Severe Asthma.

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
  • 1.50 MOC
Course opens: 
12/01/2016
Course expires: 
11/30/2019
Cost:
$45.00
Please login or create an account to take this course.

Payment required

You must purchase this course.